News for 'US Food and Drug Administration'

China apologises to Nigeria over fake drugs

China apologises to Nigeria over fake drugs

Rediff.com21 Sep 2009

China has formally apologised to Nigeria for alleged export of fake drugs including some labelled as 'Made in India' by some Chinese firms to the country and assured to take punitive action against those involved in the scandal.

Indian drug firm recalls eye drop linked to vision loss in US

Indian drug firm recalls eye drop linked to vision loss in US

Rediff.com3 Feb 2023

Global Pharma Healthcare is recalling entire lots of eye drop linked to vision loss in the US, according to the US Food and Drug Administration. The Chennai-based company is recalling all lots of artificial tears lubricant eye drops distributed by EzriCare, LLC and Delsam Pharma to the consumer level due to possible contamination, the US health regulator said in a statement. "The Centres for Disease Control and Prevention (CDC) alerted FDA to an investigation of a multi-state cluster of Verona Integron-mediated Metallo--lactamase (VIM)- and Guiana-Extended Spectrum--Lactamase (GES)- producing carbapenem-resistant Pseudomonas aeruginosa (VIM-GES-CRPA) infections possibly associated with the use of the artificial tears manufactured by Global Pharma Healthcare," USFDA said.

Nigeria flags 2 India-made drugs as substandard, having toxins

Nigeria flags 2 India-made drugs as substandard, having toxins

Rediff.com20 Jun 2023

Oral paracetamol and another cough medicine manufactured by companies based in Mumbai and Punjab were found to be "sub-standard or found to be containing toxins", reports Sohini Das.

Indian majors lead race for US drug ingredient market

Indian majors lead race for US drug ingredient market

Rediff.com30 Jan 2013

In 2012, drugs worth $35 billion went off-patent in the US, while the market size of drugs which will see patent expiry in 2013 will halve to $17 billion.

Maharashtra drug body cracks down on misleading ads

Maharashtra drug body cracks down on misleading ads

Rediff.com7 May 2012

The Maharashtra Food and Drugs Administration has initiated action against manufacturers of medicines and instruments, newspapers, TV channels and cable operators making outrageous claims through advertisements.

Wockhardt gets USFDA nod for cardiac drug

Wockhardt gets USFDA nod for cardiac drug

Rediff.com16 Aug 2012

Wockhardt said it is launching the product immediately in the US market.

Now, Ranbaxy AIDS drug under US lens

Now, Ranbaxy AIDS drug under US lens

Rediff.com22 Sep 2008

It is now probing the quality of AIDS medicines supplied by the company to developing countries under US government-funded programmes. Estimates suggest that Ranbaxy has received over $9 million from the programme so far. Ranbaxy had a turnover of $1.5 billion in 2007-08, of which a quarter came from US sales.

Wockhardt launches prostate drug in US market

Wockhardt launches prostate drug in US market

Rediff.com28 Apr 2010

Pharma major Wockhardt on Wednesday said it has launched Tamsulosin capsules, indicated for problem of prostate enlargement, in the US market on the day one of the expiry of patent covering the drug.

Cipla HIV drug gets USFDA nod

Cipla HIV drug gets USFDA nod

Rediff.com26 Jun 2006

Cipla has got tentative approval from the USFDA for its abbreviated new drug application for anti-HIV/AIDS drug Slamivudine.

US drug shortage a shot in the arm for Indian pharmaceutical companies

US drug shortage a shot in the arm for Indian pharmaceutical companies

Rediff.com26 Jun 2023

Drug shortages in the US are at an all-time high, and price erosion has stabilised, which could benefit Indian pharmaceutical (pharma) companies with a US focus, according to analysts. Nuvama Research analysts said that US price erosion seems to have normalised to its old levels of 6-8 per cent and volumes are picking up with easing of inventory. Similarly, an ICICIdirect analyst noted: "Price erosion intensity has now moderated to a single digit and is expected to tone down a

Ranbaxy forged data, says US drug regulator

Ranbaxy forged data, says US drug regulator

Rediff.com26 Feb 2009

India's largest drug manufacturer, Ranbaxy Laboratories, had falsified data and test results of medicines manufactured at its Himachal Pradesh facility to obtain marketing approval in the United States, says the US Food and Drug Administration.

US to charge fee on generic drug sale application

US to charge fee on generic drug sale application

Rediff.com21 Jun 2012

This move could cost $299 million a year for Indian pharma players.

Ranbaxy gets USFDA nod for high BP drug

Ranbaxy gets USFDA nod for high BP drug

Rediff.com5 Mar 2009

Drug-maker Ranbaxy Laboratories on Thursday said it has received the US health regulator's approval to market Quinapril Hydrochloride and Hydrochlorothiazide tablets, used in treatment of high blood pressure, in different strengths in America.

Soaring cancer drug costs may cripple medicare

Soaring cancer drug costs may cripple medicare

Rediff.com29 Jan 2009

A new report says laws crimp Medicare's ability to control costs on cancer, leading to a 267% increase in drug spending over seven years

US drug regulator to inspect Aurobindo facilities

US drug regulator to inspect Aurobindo facilities

Rediff.com16 Aug 2012

Import alert on unit-6 facility might be lifted by FDA by Sept.

Morepen files global patent for Desloratadine

Morepen files global patent for Desloratadine

Rediff.com5 Mar 2003

Indian drugmaker Morepen Laboratories Ltd has filed an international patent for the manufacturing process of Desloratadine, the Bombay Stock Exchange said on Wednesday.

Ranbaxy drug gets FDA nod

Ranbaxy drug gets FDA nod

Rediff.com1 Feb 2005

Ranbaxy Laboratories has received approval from the U.S. Food and Drug Administration to manufacture and market Clarithromycin XL 1,000 mg tablets.

Sun Pharma gets USFDA nod for epilepsy drug

Sun Pharma gets USFDA nod for epilepsy drug

Rediff.com17 Jun 2010

Drug maker Sun Pharmaceutical Industries on Thursday said it has received the US health regulator's nod for marketing a generic version of the Keppra injection, used for treating epilepsy, in the American market.

US approves first HIV-prevention drug amid protests

US approves first HIV-prevention drug amid protests

Rediff.com17 Jul 2012

For the first time, a once-a-day pill which reduces the chance of contracting HIV among high risk groups "significantly" has got green signal in the United States, where 1.2 million people are infected by the deadly disease.

Wockhardt receives US nod for cardiac drug

Wockhardt receives US nod for cardiac drug

Rediff.com23 Jul 2010

Pharmaceutical and biotechnology major, Wockhardt has received final approval from the United States Food & Drug Administration for marketing the cardiac drug.

USTR flags hurdles in medical device exports to India

USTR flags hurdles in medical device exports to India

Rediff.com2 Apr 2025

The USTR report, released just ahead of the US' April 2 deadline for implementing reciprocal tariffs, has also cited high tariffs and price caps, which have not increased in line with inflation, as key obstacles for US businesses.

Display owner's name, install cameras: UP govt cracks down on eateries

Display owner's name, install cameras: UP govt cracks down on eateries

Rediff.com24 Sep 2024

Taking cognisance of incidents of spitting and mixing of urine in eatables in Uttar Pradesh, Chief Minister Yogi Adityanath on Tuesday directed that the name and address of operators, proprietors and managers should be mandatorily displayed at all food centres.

US drug regulator raps Sun Pharma unit

US drug regulator raps Sun Pharma unit

Rediff.com5 Nov 2008

The US subsidiary of Sun Pharmaceuticals, Caraco Pharmaceutical Laboratories, has received a warning letter from the Food and Drug Administration.

Ranbaxy gets USFDA nod for new drug

Ranbaxy gets USFDA nod for new drug

Rediff.com1 Apr 2005

Ranbaxy Laboratories on Friday said it had received approval from US Food and Drug Administration to manufacture and market nitrofurantoin monohydrate macrocrystals capsules (100 mg) and planned to bring the new drug to the market in April.

Mice, roaches found in food served on US airlines

Mice, roaches found in food served on US airlines

Rediff.com21 Nov 2012

Through a Freedom of Information Act request, the Show '20/20' obtained lists of recent health violation records from the FDA, the agency in charge of inspecting airlines and their outside food caterers.

India could be 'efficacy test' for TB drug okayed by US

India could be 'efficacy test' for TB drug okayed by US

Rediff.com17 Mar 2013

There are also lingering concerns over the culture of misuse of pharmaceutical products in India, which has, in the past, led to other drugs becoming increasingly ineffective.

Ranbaxy resumes drug exports to US after 4 years

Ranbaxy resumes drug exports to US after 4 years

Rediff.com2 Apr 2012

The firm, however, said the anti-cholesterol tablets meant for the US market will be produced at its Mohali SEZ plant in Punjab and not at the three units banned by the US health regulator.

USFDA nod for Aurobindo's AIDS drug

USFDA nod for Aurobindo's AIDS drug

Rediff.com11 Jul 2005

The United States Food and Drug Administration has given tentative approval to the fixed-dose combination drug products lamivudine and zidovudine tablets -- manufactured by Aurobindo Pharma Ltd.

Maha portfolio allocation: Fadnavis gets Home, Ajit Finance, Shinde...

Maha portfolio allocation: Fadnavis gets Home, Ajit Finance, Shinde...

Rediff.com21 Dec 2024

Shiv Sena's Dadaji Bhuse is the new school education minister while Uday Samant continues to be the industries minister.

The Many Portfolios Of Yogi Adityanath

The Many Portfolios Of Yogi Adityanath

Rediff.com4 Apr 2022

In his second term in office, UP Chief Minister Yogi Adityanath has retained 34 portfolios.

India to have US FDA-like drug regulator

India to have US FDA-like drug regulator

Rediff.com23 Jun 2005

To be called Central Drug Administration or National Drug Authority, it will have 10 sub-authorities to deal with areas like cosmetics, blood safety, medical equipment, etc.

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Rediff.com30 Dec 2024

Indian pharmaceutical companies have made major strides in adhering to stringent US Food and Drug Administration (USFDA) norms in 2024, with data suggesting a decline in the number of adverse classification outcomes of inspections across biologics, drugs, and devices. In 2023, the USFDA conducted 225 inspections, which led to 18 cases of Official Action Indicated (OAI) and 117 cases of Voluntary Action Indicated (VAI).

Ranbaxy Lab dips nearly 7% on bourses

Ranbaxy Lab dips nearly 7% on bourses

Rediff.com24 Jun 2013

As per the media report, the US Food and Drug Administration is learnt to have issued a Form 483 to the company's manufacturing facility at Mohali a few months ago after finding deviations from norms during an inspection of the plant.

Indian drug firms top FDA list

Indian drug firms top FDA list

Rediff.com17 Nov 2006

With 62 filings, domestic pharma companies have filed the maximum number of drug master filings with the US Food and Drug Administration in the July-September 2006 quarter.

Ranbaxy gets FDA nod for hypertension drug

Ranbaxy gets FDA nod for hypertension drug

Rediff.com26 Apr 2004

Ranbaxy Laboratories Ltd has received the US Food and Drug Administration approval to market Fosinopril sodium tablets in the United States.

Mice, roaches found in food served on US airlines: FDA

Mice, roaches found in food served on US airlines: FDA

Rediff.com21 Nov 2012

In a shocker, the US Food and Drug Administration has discovered the presence of mice, ants and cockroaches in food served on airlines in the country.

Dawn Alliance to set up generic drug facility

Dawn Alliance to set up generic drug facility

Rediff.com2 Feb 2007

The US-based Dawn Alliance group is planning to set up a United States Food and Drug Administration-approved generic drug manufacturing facility in India.

Indian drug makers maintain pace of US mktg nod

Indian drug makers maintain pace of US mktg nod

Rediff.com4 Jan 2010

This increase is despite the decreased growth of drug sales in the US - the world's largest market - which has seen a tightening of regulations and aggressive competition.